top of page
gradientForSurfBreak.png

Item List

Jun 6, 2023
Newswire EIN
CureMatch and xCures partner to revolutionize the standard for precision cancer treatment processes

CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a partnership with xCures, Inc., to connect cancer patients and physicians with optimal investigational or approved therapies. CureMatch will leverage the xCures technology platform to create a comprehensive outline of a cancer patient’s medical history and further enhance its precision cancer treatment recommendation capabilities.

Recent Posts

Portfolio Company

Carlsmed.png

Iterative Health Acquires Cardiology Sites from NextStage Clinical Research ...

Businesswire

May 14, 2026

Portfolio Company

Carlsmed.png

Carlsmed® Reports First Quarter 2026 Financial ...

Spine Market Group

May 5, 2026

Portfolio Company

Carlsmed.png

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinica ...

Businesswire

Apr 30, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page